INS and obesity due to melanocortin 4 receptor deficiency: Thus, the same approach might be useful for administering novel drugs that reverse or bypass the blockage point of insulin signaling as an obesity treatment, once the blockage mechanism and the responsible molecules have been fully elucidated.